Farhana Khan

FDA investigator

Appears on 7 documents from 2016 to 2021, most often at sites in India. Most often cites general requirements (21 CFR 211.160).

7
Documents on file
3.6
Observations per 483
2016
First seen
2021
Most recent

What they cite most

From 25 observations

Activity by year

2016: 1, 2018: 1, 2019: 4, 2021: 1

Where

India 2 · Washington 2 · California 1 · Idaho 1 · Montana 1

Is Farhana Khan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 MakingCosmetics Inc.Mar 5, 2021 · Redmond, Washington
483 Dr. Reddy's Laboratories Ltd. Pl — PS Ql - QS, Phase III, VSEZ, DuvvadaJun 21, 2019 · Visakhapatnam, India
483 Sun Pharmaceutical Industries Ltd.Jun 11, 2019 · Halol, India
483 International Isotopes IncMay 10, 2019 · Idaho Falls, Idaho
483 Western Chemical Inc.Mar 22, 2019 · Ferndale, Washington
483 Jajco, Inc. DBA Anchor Drugs PharmacyOct 29, 2018 · South San Francisco, California
483 Montana Compounding Phatmacy P.CAug 30, 2016 · Missoula, Montana

About this profile

What does Farhana Khan inspect?

Farhana Khan appears on 7 documents on file covering 7 sites, most often in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.67 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Farhana Khan is dated Mar 5, 2021.